Corneal graft rejection occurs despite Fas ligand expression and apoptosis of infiltrating cells

British Journal of Ophthalmology

Volumn 89, Issue 5, 2005, Pages 632-638

  Williams, Keryn A ^a,b   Standfield, S D ^b   Smith, J R ^c   Coster, D J ^b  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; DYE; FAS LIGAND;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CELL NUCLEUS; CELLULAR IMMUNITY; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA TRANSPLANTATION; DOWN REGULATION; EPITHELIUM CELL; EYE PROTECTION; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; ISOGRAFT; LEUKOCYTE; NICK END LABELING; NONHUMAN; PHENOTYPE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; APOPTOSIS; CORNEAL TRANSPLANTATION; ENDOTHELIUM, CORNEAL; EPITHELIUM, CORNEAL; FAS LIGAND PROTEIN; FEMALE; GRAFT REJECTION; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; LIGANDS; MALE; MEMBRANE GLYCOPROTEINS; RATS; RATS, INBRED F344; RATS, INBRED WF;

EID: 17644422738     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2003.040675     Document Type: Article

References (48)

1. Medawar PB. Immunity to homologous grafted skin. III. The fote of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 1948;29:58-69.
2. Barker CF, Billingham RE. Immunologically privileged sites. Adv Immunol 1977;25;1-54.
3. Streilein JW, Niederkorn JY. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med 1981;153:1058-67.
4. Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol 2003;3:879-89.
5. Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-92.
6. Stuart P, Griffith TS, Usui N, et al. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest 1997;99:396-402.
7. Yamagami S, Kawashima H, Tsuru T, et al. Role of Fas-Fas-ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation 1997;64:1107-11.
8. Green DR, Ferguson TA. The role of Fas ligand in immune privilege. Nat Rev Mol Cell Biol 2001;2:917-24.
9. Williams KA, Coster DJ. Rethinking immunological privilege: implications for corneal and limbal stem cell transplantation. Mol Med Today 1997;3:495-501.
10. Coster DJ, Williams KA. Management of high-risk corneal grafts. Eye 2003;17:996-1002.
11. Williams KA, Muehlberg SM, Lewis RF, et al. How successful is corneal transplantation? A report from the Australian Corneal Graft Register. Eye 1995;9:219-27.
12. Vail A, Gore SM, Bradley BA, et al. Influence of donor and histocompatibility factors on corneal graft outcome. Transplantation 1994;58:1210-16.
13. Henderson TR, Coster DJ, Williams KA. The long term outcome of limbal allografts: the search for surviving cells. Br J Ophthalmol 2001;85:604-9.
14. Swift GJ, Aggarwal RK, Davis GJ, et al. Survival of rabbit limbal stem cell allografts. Transplantation 1996;62:568-74.
15. Ross JR, Howell DN, Sanfilippo FP. Characteristics of corneal xenograft rejection in a discordant species combination. Invest Ophthalmol Vis Sci 1993;34:2469-76.
16. Larkin DF, Takano T, Standfield SD, et al. Experimental orthotopic corneal xenotransplantation in the rat, mechanisms or graft rejection. Transplantation 1995;60:491-7.
17. Williams KA, Coster DJ. Penetrating corneal transplantation in the inbred rat: a new model. Invest Ophthalmol Vis Sci 1985;26:23-30.
18. Takano T, Williams KA. Mechanism of corneal endothelial destruction in rejecting rat corneal allografts and xenografts: a role for CD4+ cells. Transplant Proc, 1995;b, 260-1.
19. McLean IW, Nakane PK. Periodate-lysine-paraformaldehyde fixative: a new fixative for immunoelectron microscopy. J Histochem Cytochem 1974;22:1077-83.
20. Smith JR, Hart PH, Standfield SD, et al. Apoptosis of infiltrating cells is prominent in acute anterior uveitis in the Fischer 344 rat. Br J Ophthalmol 2000;84:205-11.
21. Tilley WD, Lim-Tio SS, Horsfall DJ, et al. Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by video image analysis. Cancer Res 1994;54:4096-102.
22. Yanagihara K, Tsumuraya M. Transforming growth factor β1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 1992;52:4042-5.
23. Ren H, Wilson G. Apoptosis in the corned epithelium. Invest Ophthalmol Vis Sci 1996;37:1017-25.
24. Holland EJ, Olsen TW, Chan CC, et al. Kinetics of corneal transplant rejection in the rat penetrating keratoplasty model. Cornea 1994;3:317-23.
25. Larkin DF, Calder VL, Lightman SL. Identification and characterization of cells infiltrating the graft and aqueous humour in rat corneal allograft rejection. Clin Exp Immunol 1997;107:381-91.
26. Claerhout I, Kestelyn P, Debacker V, et al. Role of natural killer cells in the rejection process of corneal allografts in rats. Transplantation 2004;77:676-82.
27. Kayagaki N, Kawasaki A, Ebata T, et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995;182:1777-83.
28. Tanaka M, Itai T, Adachi M, et al. Downregulation of Fas ligand by shedding. Nat Med 1998;4:31-6.
29. Brunner T, Wasem C, Torgler R, et al. Fas (CD95/Apo-1) ligand regulation in T cell homeostasis, cell-mediated cytotoxicity and immune pathology. Sem Immunol 2003;15:167-76.
30. Wong B, Arron J, Chai Y. T cell receptor signals enhance susceptibility to Fas-mediated apoptosis. J Exp Med 1997;186:1939-44.
31. Siegal RM, Chan FK, Chun HJ, et al. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 2000;1:469-74.
32. Wilson SE, Li Q, Weng J, et al. The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest Ophthalmol Vis Sci 1996;37:1582-92.
33. Yamamoto K, Ladage PM, Ren DH, et al. Bcl-2 expression in the human cornea. Exp Eye Res 2001;73:247-55.
34. Yanai R, Yamada N, Kugimiya N, et al. Mitogenic and antiapoptotic effects of various growth factors on human corneal fibroblasts. Invest Ophthalmol Vis Sci 2002;43:2122-6.
35. Gain P, Thuret G, Chiquet C, et al. Value of two mortality assessment techniques for organ cultured corneal endothelium: trypan blue versus TUNEL technique. Br J Ophthalmol 2002;86:306-10.
36. Albon J, Tullo AB, Aktar S, et al. Apoptosis in the endothelium of human corneas for transplantation. Invest Ophthalmol Vis Sci 2000;41:2887-93.
37. Ansari B, Coates PJ, Greenstein BD, et al. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol 1993;170:1-8.
38. Gold R, Schmied M, Rothe G, et al. Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture systems and tissue sections. J Histochem Cytochem 1993;41:1023-30.
39. Williams KA, Coster DJ. Clinical and experimental aspects of corneal transplantation. Transplantation Reviews 1993;7:44-64.
40. Williams KA, Standfield SD, Wing SJ, et al. Patterns of corneal graft rejection in the rabbit and reversal of rejection with monoclonal antibodies. Transplantation 1992;54:38-43.
41. Ayliffe W, Alam Y, Bell EB, et al. Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br J Ophthalmol 1992;76:602-6.
42. Marris RG, Hargreaves AD, Duvall E, et al. Hormone-induced cell death. 2 Surface changes in thymocytes undergoing apoptosis. Am J Pathol 1984;115:426-36.
43. Strasser A. Death of a cell. Nature 1995;373:385-6.
44. Sonoda KH, Tabiguchi M, Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reacitive NKT cells. J Immunol 2002;168:2028-34.
45. Bellgrau D, Gold D, Selawry H, et al. A role for CD95 ligand in preventing graft rejection. Nature 1995;377:630-2.
46. Vaux DL. Ways around rejection. Nature 1995;377:576-7.
47. Lau HT, Yu M, Fontana A, et al. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996;273:109-12.
48. Allison J, Georgiou HM, Strasser A, et al. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci USA 1997;94:3943-7.